Shire open to AbbVie’s upped offer of £31 billion
AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last week’s offer of £51.15....
Glenmark Generics receives final ANDA approval for Telmisartan tablets
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited has been granted final...
Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment Japanese HCV...
Rotavirus Vaccination Decreases Diarrhea Hospitalizations Among Kids
Since the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. Diarrhea-related health care...
GenOway offers industry scientists immediate access to EUCOMM conditional KO mouse models
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists Lyon, France, July 2, 2014 -...
Boehringer Ingelheim Statement on Hepatitis C drug development
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to move forward in this...
Soon, get HIV tests done at UK supermart
Britons can now get a quick HIV test — in 60 seconds flat, when they visit a supermarket. A British sexual health charity has...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...